Stevanato Group S.p.A (STVN) Other Non-Current Assets (2020 - 2026)
Stevanato Group S.p.A (STVN) reported Other Non-Current Assets of $7.5 million for Q1 2026, down 49.76% year-over-year from $14.9 million in Q1 2025, and up 10.91% quarter-over-quarter from $6.8 million in Q4 2025.
Stevanato Group S.p.A (STVN) Other Non-Current Assets (2020 - 2026) Analysis & Trends
Stevanato Group S.p.A (STVN) has 7 years of Other Non-Current Assets data on file, last reported at $7.5 million in Q1 2026.
- Other Non-Current Assets for Q1 2026 came in at $7.5 million, down 49.76% year-over-year; the trailing twelve-month figure through Mar 2026 was $7.5 million (down 49.76% YoY), and the FY2025 annual result was $6.8 million, up 17.2% from the prior year.
- Other Non-Current Assets improved to $7.5 million in Q1 2026 per STVN's latest filing, from $6.8 million in the prior quarter.
- Over five years, Other Non-Current Assets peaked at $15.6 million in Q3 2025 and troughed at $920554.5 in Q3 2022.
- A 5-year average of $6.4 million and a median of $6.0 million in 2024 frame the typical range for Other Non-Current Assets.
- The sharpest annual moves came in 2022 and 2023: Other Non-Current Assets plunged 70.42% in 2022, then jumped 559.26% in 2023.
- A 5-year view of Other Non-Current Assets shows it stood at $1.0 million in 2022, then soared by 374.56% to $4.8 million in 2023, then gained by 19.18% to $5.8 million in 2024, then gained by 17.2% to $6.8 million in 2025, then grew by 10.91% to $7.5 million in 2026.
- Business Quant data shows STVN's Other Non-Current Assets at $7.5 million in Q1 2026, $6.8 million in Q4 2025, and $15.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | - |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | 2.43 Bn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 446.00 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 210.73 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 81.30 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 848.00 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | 672.80 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 39.83 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 692.00 Mn |
| 10 | Stevanato Group S.p.A | 433.37 Mn | 290.42 Mn | 88.01 Mn | 7.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.50 Mn |
| Dec 31, 2025 | 6.76 Mn |
| Sep 30, 2025 | 15.60 Mn |
| Jun 30, 2025 | 15.19 Mn |
| Mar 31, 2025 | 14.93 Mn |
| Dec 31, 2024 | 5.77 Mn |
| Sep 30, 2024 | 6.04 Mn |
| Jun 30, 2024 | 6.07 Mn |
| Mar 31, 2024 | 5.08 Mn |
| Dec 31, 2023 | 4.84 Mn |
| Sep 30, 2023 | 6.07 Mn |
| Jun 30, 2023 | 6.16 Mn |
| Mar 31, 2023 | 4.00 Mn |
| Dec 31, 2022 | 1.02 Mn |
| Sep 30, 2022 | 920,554.46 |
| Jun 30, 2022 | 961,418.08 |
| Mar 31, 2022 | 1.50 Mn |
| Dec 31, 2021 | 1.49 Mn |
| Sep 30, 2021 | 3.11 Mn |
| Jun 30, 2021 | 3.15 Mn |